Savara, Inc. (SVRA)
4.78
-0.06
(-1.24%)
USD |
NASDAQ |
Oct 13, 16:00
4.87
+0.09
(+1.88%)
After-Hours: 20:00
Savara EPS Diluted (TTM) : -0.5766 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5766 |
| March 31, 2026 | -0.5584 |
| December 31, 2025 | -0.5344 |
| September 30, 2025 | -0.5351 |
| June 30, 2025 | -0.513 |
| March 31, 2025 | -0.4943 |
| December 31, 2024 | -0.4825 |
| September 30, 2024 | -0.4372 |
| June 30, 2024 | -0.4237 |
| March 31, 2024 | -0.3768 |
| December 31, 2023 | -0.3345 |
| September 30, 2023 | -0.3124 |
| June 30, 2023 | -0.2794 |
| March 31, 2023 | -0.2645 |
| December 31, 2022 | -0.2497 |
| September 30, 2022 | -0.2815 |
| June 30, 2022 | -0.2826 |
| March 31, 2022 | -0.2944 |
| December 31, 2021 | -0.3728 |
| September 30, 2021 | -0.5273 |
| June 30, 2021 | -0.6417 |
| March 31, 2021 | -0.7294 |
| December 31, 2020 | -0.8655 |
| September 30, 2020 | -1.336 |
| June 30, 2020 | -1.449 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.860 |
| December 31, 2019 | -1.928 |
| September 30, 2019 | -1.497 |
| June 30, 2019 | -1.572 |
| March 31, 2019 | -1.382 |
| December 31, 2018 | -1.924 |
| September 30, 2018 | -1.862 |
| June 30, 2018 | -1.769 |
| March 31, 2018 | -2.289 |
| December 31, 2017 | -116.91 |
| September 30, 2017 | -117.94 |
| June 30, 2017 | -202.36 |
| March 31, 2017 | -339.36 |
| December 31, 2016 | -228.06 |
| September 30, 2016 | -231.00 |
| June 30, 2016 | -150.50 |
| March 31, 2016 | -16.80 |
| December 31, 2015 | -16.80 |
| September 30, 2015 | -16.10 |
| June 30, 2015 | -16.10 |
| March 31, 2015 | -16.10 |
| December 31, 2014 | -16.10 |
| September 30, 2014 | -16.80 |
| June 30, 2014 | -16.10 |
| March 31, 2014 | -18.20 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Gilead Sciences, Inc. | -2.656 |
| Insmed, Inc. | -4.105 |
| United Therapeutics Corp. | 27.96 |
| Vertex Pharmaceuticals, Inc. | 17.19 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |